Novartis Can Relieve Investor Stress (NVS)
August 4th, 2008

Novartis (NVS) shares are up nearly 3% today, after the FDA (Food and Drug Administration) approved the drugs Diovan HCT and Exforge as initial treatments for high blood pressure. According to the company, high blood pressure affects one in four adults worldwide.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!



Stock Screener
RSS

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the